Bertrand Loy Entegris Inc (ENTG) insider trading activity

Bertrand Loy is President & CEO of ENTEGRIS INC. Currently has a direct ownership of 263,068 shares of ENTG, which is worth approximately $26 Million. The most recent transaction as insider was on Jul 03, 2024, when has been sold 27,044 shares (Common Stock) at a price of $141.29 per share, resulting in proceeds of $3,821,046. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 263K

0% 3M change

14.78% 12M change

Total Value Held $26 Million

BERTRAND LOY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 03 2024	SELL Open market or private sale	$3,821,046 $141.29 p/Share	27,044 Reduced 9.32%	263,068 Common Stock
Jul 03 2024	BUY Exercise of conversion of derivative security	$841,068 $31.1 p/Share	27,044 Added 8.53%	290,112 Common Stock
Apr 01 2024	BUY Grant, award, or other acquisition	-	38,208 Added 12.68%	263,068 Common Stock
Feb 20 2024	SELL Payment of exercise price or tax liability	$1,245,928 $136.81 p/Share	9,107 Reduced 3.89%	224,860 Common Stock
Feb 20 2024	BUY Grant, award, or other acquisition	-	20,534 Added 8.07%	233,967 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$2,155,578 $136.81 p/Share	15,756 Reduced 6.87%	213,433 Common Stock
Aug 15 2023	SELL Payment of exercise price or tax liability	$897,055 $95.87 p/Share	9,357 Reduced 3.92%	229,189 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$1,207,490 $85.48 p/Share	14,126 Reduced 5.59%	238,546 Common Stock
Feb 13 2023	SELL Payment of exercise price or tax liability	$741,271 $84.94 p/Share	8,727 Reduced 3.34%	252,672 Common Stock
Feb 13 2023	BUY Grant, award, or other acquisition	-	19,676 Added 7.0%	261,399 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	-	51,292 Added 17.5%	241,723 Common Stock
Aug 15 2022	SELL Payment of exercise price or tax liability	$986,134 $105.39 p/Share	9,357 Reduced 4.68%	190,431 Common Stock
Jul 06 2022	BUY Grant, award, or other acquisition	-	116 Added 0.06%	199,788 Common Stock
Feb 18 2022	SELL Payment of exercise price or tax liability	$1,958,448 $130.19 p/Share	15,043 Reduced 7.01%	199,672 Common Stock
Feb 11 2022	SELL Payment of exercise price or tax liability	$1,326,085 $124.48 p/Share	10,653 Reduced 4.73%	214,715 Common Stock
Feb 11 2022	BUY Grant, award, or other acquisition	-	24,020 Added 9.63%	225,368 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	27,248 Added 11.92%	201,348 Common Stock
Aug 09 2021	SELL Open market or private sale	$1,189,762 $121.33 p/Share	9,806 Reduced 5.33%	174,100 Common Stock
Aug 04 2021	SELL Open market or private sale	$2,137,750 $125.75 p/Share	17,000 Reduced 8.46%	183,906 Common Stock
Apr 14 2021	SELL Open market or private sale	$11,853,000 $118.53 p/Share	100,000 Reduced 33.23%	200,906 Common Stock
Apr 13 2021	SELL Open market or private sale	$11,852,000 $118.52 p/Share	100,000 Reduced 24.94%	300,906 Common Stock
Apr 12 2021	SELL Open market or private sale	$11,977,000 $119.77 p/Share	100,000 Reduced 19.96%	400,906 Common Stock
Apr 05 2021	SELL Open market or private sale	$36,810,398 $122.52 p/Share	300,444 Reduced 37.49%	500,906 Common Stock
Apr 05 2021	BUY Exercise of conversion of derivative security	$10,647,735 $35.44 p/Share	300,444 Added 27.27%	801,350 Common Stock
Feb 19 2021	SELL Payment of exercise price or tax liability	$2,867,809 $105.57 p/Share	27,165 Reduced 5.14%	500,906 Common Stock

Also insider at

HBIO

HARVARD BIOSCIENCE INC Healthcare

Director

Bertrand Loy

President & CEO

Billerica, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENTG shares.

Notify only if

Value

Insider Trading

Get notified when an Entegris Inc insider buys or sells ENTG shares.

Notify only if

Operation

Value

Type

News

Receive news related to ENTEGRIS INC

Track Activities on ENTG

Account